AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-2.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$3.82B
(+1.8%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
29.38%
Holding
407
New
72
Increased
84
Reduced
67
Closed
155
Top Buys
| 1 |
Alkermes
ALKS
|
$48.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$45.5M |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$37.9M |
| 4 |
Simply Good Foods
SMPL
|
$34.6M |
| 5 |
Immunovant
IMVT
|
$32.5M |
Top Sells
| 1 |
Rigel Pharmaceuticals
RIGL
|
$113M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$92.8M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$38.2M |
| 4 |
Coca-Cola
KO
|
$37M |
| 5 |
argenx
ARGX
|
$27.5M |
Sector Composition
| 1 | Healthcare | 68.75% |
| 2 | Consumer Staples | 10.83% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Technology | 7.69% |
| 5 | Materials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biohaven
BHVN
$1.68B
| $48.5M | 0.61% |
1,396,968
+597,705
| +75% | +$20.7M |
|
27
Kura Oncology
KURA
$690M
| $48.4M | 0.61% |
2,350,000
+302,000
| +15% | +$6.22M |
|
28
Campbell Soup
CPB
$9.38B
| $48.3M | 0.61% |
1,067,914
+517,550
| +94% | +$23.4M |
|
29
Madrigal Pharmaceuticals
MDGL
$9.76B
| $42M | 0.53% |
150,000
-18,000
| -11% | -$5.04M |
|
30
Voyager Therapeutics
VYGR
$186M
| $41.1M | 0.52% |
5,200,000
+528,000
| +11% | +$4.18M |
|
|
BCYC
31
Bicycle Therapeutics
BCYC
$511M
| $39.9M | 0.5% |
1,972,000
+300,000
| +18% | +$6.07M |
|
32
Humana
HUM
$36.5B
| $38.7M | 0.49% |
103,694
-21,490
| -17% | -$8.03M |
|
33
Spectrum Brands
SPB
$1.38B
| $37.8M | 0.48% |
439,377
+247,809
| +129% | +$21.3M |
|
34
Treace Medical Concepts
TMCI
$453M
| $35.6M | 0.45% |
5,360,000
+2,960,000
| +123% | +$19.7M |
|
35
Toast
TOST
$25.5B
| $35.1M | 0.44% |
1,362,569
+427,882
| +46% | +$11M |
|
|
36
Simply Good Foods
SMPL
$2.88B
| $34.6M | 0.44% |
+957,163
| New | +$34.6M |
|
37
Dyne Therapeutics
DYN
$1.92B
| $34.3M | 0.43% |
970,891
-29,109
| -3% | -$1.03M |
|
38
Workday
WDAY
$61.6B
| $33.6M | 0.42% |
150,476
+109,164
| +264% | +$24.4M |
|
39
Immunocore
IMCR
$1.63B
| $33.1M | 0.42% |
976,000
+812,000
| +495% | +$27.5M |
|
40
Prothena Corp
PRTA
$441M
| $32.2M | 0.41% |
1,560,000
+464,000
| +42% | +$9.58M |
|
41
DocuSign
DOCU
$15B
| $32M | 0.4% |
597,921
-205,754
| -26% | -$11M |
|
42
FIVE9
FIVN
$2.04B
| $31.9M | 0.4% |
722,582
+261,476
| +57% | +$11.5M |
|
43
Intuitive Surgical
ISRG
$170B
| $31.7M | 0.4% |
71,227
+28,250
| +66% | +$12.6M |
|
44
Thermo Fisher Scientific
TMO
$186B
| $31.1M | 0.39% |
56,158
+41,182
| +275% | +$22.8M |
|
|
NVRO
45
DELISTED
NEVRO CORP.
NVRO
| $30.9M | 0.39% |
3,672,000
+48,000
| +1% | +$404K |
|
46
Boston Beer
SAM
$2.41B
| $29.7M | 0.37% |
97,292
+1,093
| +1% | +$333K |
|
47
Starbucks
SBUX
$102B
| $29.1M | 0.37% |
373,250
-96,820
| -21% | -$7.54M |
|
48
Kenvue
KVUE
$39.7B
| $28.9M | 0.36% |
1,588,358
+145,329
| +10% | +$2.64M |
|
49
Treehouse Foods
THS
$926M
| $28.7M | 0.36% |
783,000
+85,000
| +12% | +$3.11M |
|
50
Kellanova
K
$27.6B
| $26M | 0.33% |
451,544
-126,376
| -22% | -$7.29M |
|